weight loss
tailored to you
We use a subcutaneous weekly injection of diet medications to help you lose weight. Commonly known as the Hollywood miracle weight loss drug. Typically patients are seeing a 1-2lb loss per day after 2-3 weeks.
semaglutide
Ingredient: semaglutide
Drug Facts
Frequency: 1 weekly shot
Application: subcutaneous injection
Dosage: .25mg - 2.5mg
tirzepatide
Ingredient: tirzepatide
Drug Facts
Frequency: 1 weekly shot
Application: subcutaneous injection
Dosage: 2.5mg - 15mg
As an alternative to FDA-approved branded products, in certain cases, a healthcare provider may prescribe a compounded drug, which is prepared by a state-licensed sterile compounding pharmacy partner. While compounded drugs are permitted under federal law, they do not undergo the same safety, effectiveness, or manufacturing review process as FDA-approved medications.
semaglutide
Ingredient:
semaglutide
Drug Facts
Frequency: 1 weekly shot
Application: subcutaneous injection
Dosage: .25mg - 2.5mg
tirzepatide
Ingredient:
tirzepatide
Drug Facts
Frequency: 1 weekly shot
Application: subcutaneous injection
Dosage: 2.5mg - 15mg
As an alternative to FDA-approved branded products, in certain cases, a healthcare provider may prescribe a compounded drug, which is prepared by a state-licensed sterile compounding pharmacy partner. While compounded drugs are permitted under federal law, they do not undergo the same safety, effectiveness, or manufacturing review process as FDA-approved medications.
| semaglutide | tirzepatide | diet pills | |
|---|---|---|---|
|
prescription based Unlike over-the-counter medications, GLP-1s |
|||
|
fast weight loss GLP-1 medications like tirzepatide have shown |
| semaglutide | tirzepatide | diet pills | |
|---|---|---|---|
| prescription based
Unlike over-the-counter medications, GLP-1s |
|||
| fast weight loss
GLP-1 medications like tirzepatide have shown |
15-20%
On average, people on semaglutide or tirzeparide lose 15-20% of their weight in a year*
*In a 68- and 72-week clinical trial examining Semaglutide (2.4 mg) and Tirzepatide (15 mg) in patients without diabetes and with a BMI ≥30, or BMI ≥27 with a weight-related condition, the average weight loss was 15% and 20%, respectively, when combined with dietary and exercise modifications. This is compared to weight losses of 2.4% and 3.1%, respectively, with diet and exercise alone.
15-20%
On average, people on semaglutide or tirzeparide lose 15-20% of their weight in a year*
*In a 68- and 72-week clinical trial examining Semaglutide (2.4 mg) and Tirzepatide (15 mg) in patients without diabetes and with a BMI ≥30, or BMI ≥27 with a weight-related condition, the average weight loss was 15% and 20%, respectively, when combined with dietary and exercise modifications. This is compared to weight losses of 2.4% and 3.1%, respectively, with diet and exercise alone.